Media > Posts

OUR PROGRESS IN SEPTEMBER 2026

October 13, 2026

OUR PROGRESS IN SEPTEMBER 2026

WP8 Development of Network Activities

Welcome to the September 2026 edition of the EUnetCCC WP8 newsletter!

September brought the network back together in person. The survivorship community met in Brussels, the guidelines core group worked in Ljubljana and the MTB Summit in Rome brought together nearly 200 participants.

Several tasks are now preparing their sessions for the Annual Meeting in Lisbon in November, and the first Guidelines Exchange Programme meeting takes place in Brno on 8 October. Read on for the latest updates from across WP8.

 

Task 8.1 Framework & Infrastructure 

Development EUnetCCC webinar guide

The EUnetCCC webinar guide is ready, and is available in the Tool Kit on SharePoint. In it you can find useful tips for organising webinars, and a step by step guide to how to organise webinars in Teams.

See Guide here 

Task 8.2.1 Guidelines

From summer break to autumn action: guideline group turning plans into progress September marked the restart of activities following the summer break, with a warm welcome back to our core group members and participants. A key milestone was our core group working meeting in Ljubljana, kindly hosted by the Institute of Oncology Ljubljana.

Discussions focused on the ongoing development of quality indicators, collaboration with major European medical societies, outreach to patient organisations and continued preparations for the Guidelines Exchange Programme. The core team also had the opportunity to visit the Institute's surgical and radiotherapy departments.

Looking ahead, we are excited for the first Guidelines Exchange Programme meeting, which will take place on 8 October in Brno. The event will bring together cancer centres from the Czech Republic, Spain, Sweden, Portugal, Slovenia, Bulgaria, Norway and Moldova to exchange experiences, share good practices and strengthen collaboration on guideline implementation across Europe.

See full article here. 

 

Task 8.2.2 Personalized Cancer Prevention

From tools to implementation: advancing the Cancer Prevention Hub Framework

During September, Task 8.2.2 continued to consolidate the practical components of the Cancer Prevention Hub Framework. The task partners reviewed the risk-factor tools developed for personalised primary and secondary prevention, with the aim of finalising them and integrating them into the broader framework. In parallel, work continued on the Cancer Prevention Hub manuscript, including refinement of its scope, structure and key messages, as well as on the patient/caregiver history tool and its alignment with the other prevention checklists developed within the task.

At the same time, the task has moved forward with planning its next implementationfocused activities. Preparations are underway for the March 2027 activities at Lillebaelt Hospital in Denmark, where the WP8 T8.2.2 Prevention Teaming and the WP6 Prevention Pairing Programme will be closely coordinated. This will provide an opportunity to connect the Cancer Prevention Hub work developed within WP8 with practical institutional implementation, peer learning and capacity building.

During September, the Cancer Prevention Hub manuscript underwent another round of review and consolidation with contributions from task partners. The task is also preparing its contribution to the EUnetCCC Annual Meeting in Lisbon in November 2026, where personalised cancer prevention and the development of Cancer Prevention Hubs across European Comprehensive Cancer Centres will be presented and discussed.

 

Task 8.2.4 Precision Diagnostics

Countdown to the MTB Summit and call for interest in liquid biopsy activities

Final preparations have been underway for the MTB Summit, taking place 24-25 September, bringing together nearly 200 participants. Beyond the packed core programme, the Summit is also leveraged as a strategic opportunity to host a site tour of the IRE facilities, to conduct interviews with key selected stakeholders and to meet with representatives from other JAs, including JA PCM and JANE-2, to plan collaborative activities.

The programme for the webinar on improving access to precision diagnostics for all eligible patients: collaboration between CCCs and CCCNs has also been finalised and all speakers confirmed. This webinar reflects a joint collaboration between WP8.2.4 (Precision Diagnostics) and WP9 (CCCNs), with invitations for input from WP6 (Capacity Building). Patient representatives have also already prepared important questions and will contribute as moderators or panellists.

A call for interest in joining liquid biopsy activities has been opened on 9 September, to organise working groups, site visits and events, and to prepare outputs and resources following these activities. Meetings with JA PCM stakeholders have also been initiated, to discuss shared activities. If you are interested in participating, please register here.

 

Task 8.2.5 Secondary Use of Clinical Data

Collaboration and alignment

Subtask 8.2.5 is advancing work across two closely connected areas: Improving data at the source and Childhood Cancer Equity. Together, they address how better use of clinical data and stronger cross-border collaboration can contribute to more effective, knowledgedriven and equitable cancer care.

Through Improving data at the source, the working group is continuing its first pilot study, exploring how clinical data can be made more structured and reusable from the outset. The aim is to support quality improvement, research and the future implementation of the European Health Data Space. Initial results from the pilot will be presented at the EUnetCCC Annual Meeting in Lisbon in November.

Subtask 8.2.5 was represented at the FALCON Symposium and Bladder Cancer Studyathon in Antwerp from 28 September to 1 October. The studyathon brings together data partners and collaborators to carry out federated analyses using the OMOP common data model. Participation provides valuable practical experience of methods for generating rigorous, reproducible and guideline-relevant real-world evidence, while also strengthening links between 8.2.5 and the wider European data community. The subtask has also contributed to a joint Horizon Europe proposal on Virtual Human Twins for cancer research. The proposed collaboration brings together 20 partners from 12 countries, including 12 centres participating in EUnetCCC.

Through Childhood Cancer Equity, the subtask is exploring how collaboration across countries can help reduce inequalities in access to specialised expertise, clinical trials and high-quality childhood cancer care. From 13 to 15 October, around 30 participants from Iceland and the Nordic-Baltic countries will gather in Stockholm for a workshop to identify shared needs, opportunities for collaboration and practical next steps. The workshop is being developed in collaboration with Subtask 8.2.6 on clinical trials and through continued engagement with the EUnetCCC Paediatric & AYA Cancers Task Force. Looking ahead, Subtask 8.2.5 will continue to develop its pilot activities, strengthen collaboration with relevant European data initiatives and explore synergies with JA Cancer Watch and PHEMS.

 

Task 8.2.6 Clinical Trials

Clinical Trials in focus: strengthening networks and empowering patients

This month, the Clinical Trials Task would like to highlight its contribution to the EUnetCCC Annual Meeting, taking place in November 2026. The task team will lead and/or contribute to two sessions focused on strengthening clinical trial activities across Europe. These sessions will showcase how Comprehensive Cancer Centres can collaborate to improve trial delivery, share expertise and resources, promote peer-to-peer learning and expand patient access to clinical research. Discussions will also address disparities in clinical trial capacity across centres and explore ways to build a more coordinated and sustainable European clinical trials ecosystem.

Patient involvement continues to be a key priority within EUnetCCC. Following discussions held in Tallinn, work is progressing on a two-stage initiative aimed at helping patients identify ongoing and upcoming clinical trials across Europe. During autumn 2026, the focus is on mapping and organising existing resources, including CTIS, national and institutional platforms and materials developed by patient organisations. This work is being | carried out in close collaboration with patient representatives from several countries through a co-creation process. One meeting was held in June, and a second is planned for the end of September. In 2027, the resulting resource will likely be launched through a dedicated section of the EUnetCCC website, supported by dissemination activities to increase awareness and accessibility for patients and patient organisations across Europe.

 

Task 8.2.7 Cancer Survivorship

From screening to implementation: advancing the Survivorship Care Hub in Brussels

September marked an important milestone for Task 8.2.7 with the Survivorship Teaming Activity held on 17-18 September at Cliniques universitaires Saint-Luc in Brussels. The meeting brought together the different Technical Working Groups, CCC representatives and patient perspectives to connect the work developed so far and move towards a common approach for implementing survivorship care across European Comprehensive Cancer Centres.

A major focus was the further development of the Survivorship Care Hub and its Implementation Framework (IF-SurvHub). Discussions addressed screening and risk stratification, supportive and rehabilitation needs, psycho-oncology, late effects and followup and social, financial and vocational support. The task is bringing these components together within one navigator-coordinated survivorship pathway, from diagnosis through treatment and into long-term survivorship. Following Brussels, partners are also strengthening alignment with JANE-2, particularly around Survivorship Care Plans and complementary survivorship models, while the individual TWGs continue refining their practical tools and implementation guidance.

 

Task 8.2.8 Governance of CCCs

Planning, preparation and promotion 

The summer has been a period of consolidation and learning for the subtask. In September we concluded our consultation on the Collegial Interview Programme, which began by gathering feedback and ideas from participating CCCs before extending the discussion across our Core Group. The resulting learnings and improvement ideas are being incorporated into the next round of Collegial Interviews, as well as into other future activities designed to foster mutual learning between CCC leadership teams.

Recruitment into the Collegial Interview Programme continues, and we will have a (social) meeting at the Annual Meeting to give participating and candidate CCCs an opportunity to meet and engage informally.

Finally, we were pleased to attend and support the WP6 workshop, "Advancing Equality and Excellence Across Diverse Healthcare Systems". This was a valuable opportunity to build understanding of how aspiring CCCs in SMS and UHEs are tackling challenges of governance, organisation and leadership.

 

Task 8.3 Dissemination & Evaluation

A new rhythm for the newsletter and work towards Lisbon

Starting with the October edition, the WP8 newsletter will be published in the month it covers. In September we also started work on two publications for the Annual Meeting in Lisbon. Content collection for the EUnetCCC Booklet 2026 opened at the end of the month, with each work package invited to share results and highlights from the first two years of the Joint Action. Updates for the WP8 Network Activities Brochure are being worked into the new version. Both are being prepared for the Annual Meeting in November.

 

ANNOUNCEMENTS

EUnetCCC Policy update

On 28 September 2026, the European Parliament's Committee on Public Health (SANT) adopted its report assessing the implementation of Europe's Beating Cancer Plan, by 27 votes to 8 with 5 abstentions. This is an own-initiative report: it is not new legislation and does not in itself allocate funding or create new obligations. It does set out the priorities the European Parliament wishes to defend for the next phase of EU cancer policy, at a moment when discussions on the 2028-2034 EU budget are under way.

Several passages are of particular relevance to EUnetCCC. The report welcomes the creation of the EU Network of National Comprehensive Cancer Centres and describes them as integrated and interconnected hubs for multidisciplinary care, research, innovation and training. It recalls the objective of ensuring that 90% of eligible patients have access to National Comprehensive Cancer Centres by 2030 and calls for adequate support and sustainable funding for the establishment and accreditation of these centres. On funding, the Committee calls for EUR 10.05 billion to be earmarked for EU4Health priorities in the 2028-2034 budget, with a minimum of EUR 2.5 billion for cancer-related actions. It also asks the Commission to make a dedicated European Investment Bank facility available to the centres and calls for successful initiatives funded under the Plan to be continued beyond their initial funding cycles. The report will now go to the European Parliament plenary for a final vote. The EUnetCCC Coordination Team will keep the consortium informed of the next steps.

Read the press release here. 

Read the report text here.

 

EUnetCCC Patient Involvement

EUnetCCC launches its Patient Involvement Task Force

On 30 September 2026, EUnetCCC held the first meeting of its Patient Involvement Task Force, bringing together patient representatives and project colleagues to strengthen the involvement of patients, survivors and caregivers across the Joint Action.

A central message was clear: patients need to be involved from the beginning, while they can still help shape priorities, activities and decisions.

Visit the Patient Involvement Page.

 

Task 8.2.7 Cancer Survivorship

Successful T8.2.7 Survivorship Teaming Activity in Brussels, 17-18 September 2026

The Task 8.2.7 community met in Brussels for two days of intensive work on translating survivorship principles into an implementable model for European CCCs. The meeting provided an opportunity to bring together the different Technical Working Groups, compare approaches and identify how their outputs can be integrated into the Survivorship Care Hub and its Implementation Framework.

The Brussels discussions have already generated new follow-up activities, including closer coordination with JANE-2 on Survivorship Care Plans and further development of a network of clinical social workers within CCCs, supporting the translation of the social, financial and vocational work into daily practice.

Task 8.2.7 will also present an update on its work during the EUnetCCC webinar on 29 October 2026.

Read article here.

 

UPCOMING EVENTS

October 8, 2026 Task 8.2.1 | Guidelines

Guidelines Exchange Programme meeting in Brno 

Participants from cancer centres in the Czech Republic, Spain, Sweden, Portugal, Slovenia, Bulgaria, Norway and Moldova will gather in Brno for a full day of knowledge exchange and discussion. The meeting will be hosted by Masaryk Memorial Cancer Institute and moderated by the Guidelines Lead Team. The programme will focus on guideline implementation in clinical practice, collaboration between centres and networks, adherence to clinical guidelines, quality indicators, patient involvement and equity in cancer care.

Masaryk Memorial Cancer Institute, Brno

 

November 4, 2026 Task 8.2.1 | Guidelines

Guidelines Exchange Programme meeting in Hamburg 

The next Guidelines Exchange Programme event, hosted by University Medical Center Hamburg- Eppendorf / University Cancer Center Hamburg (UCCC Hamburg).

UCCC Hamburg, Germany

 

Task 8.2.4 | Precision Diagnostics Webinar: 

Improving access for all eligible patients to Precision Diagnostics

This webinar will explore how reference Comprehensive Cancer Centres (CCCs) and CCC networks (CCCNs) can operationalise the referral pathways to ensure that all eligible patients in a region have access to advanced precision diagnostics and molecular tumour boards (MTBs). A joint collaboration between Task 8.2.4 and WP9.

Online

Date to be announced 

Register here

 

November 26-27, 2026 EUnetCCC | Annual Meeting

EUnetCCC Annual Meeting 2026

The main annual gathering of the EUnetCCC network, bringing partners together in Lisbon. WP8 tasks will contribute several sessions, including a session on the transition from population prevention to personalised prevention and the role of Cancer Prevention Hubs (Task 8.2.2) and a session dedicated to cancer survivorship (Task 8.2.7).

Read more and register

Lisbon Congress Centre, Portugal

 

March 3-4, 2027 Task 8.2.2 | Personalized Cancer Prevention

Prevention Teaming at Lillebaelt Hospital

The next Prevention Teaming activity will focus on the practical implementation of personalised prevention within Comprehensive Cancer Centres, including the Cancer Prevention Hub model, organisational pathways and approaches for reaching caregivers and people accompanying cancer patients.

Lillebaelt Hospital, Denmark

 

March 4-5, 2027 Task 8.2.2 | with WP6

WP6 Prevention Pairing Programme

The WP6 Pairing visit will bring together Lillebaelt Hospital and the Oncology Institute "Prof. Dr. Ion Chiricuță" Cluj-Napoca (IOCN), with Lillebaelt acting as the coaching centre. The overlap with the Prevention Teaming is intentional and will help connect the prevention model developed within WP8 with the institutional capacity-building work of WP6.

Lillebaelt Hospital, Denmark

 

Q1 2027 Task 8.2.7 | Cancer Survivorship 

Survivorship Teaming Activity in Luxembourg

The next Survivorship Teaming Activity, planned for the first quarter of 2027 and most likely in March, will continue the collaborative implementation work initiated during the previous teamings. The detailed programme and exact dates will be announced as planning progresses.

Luxembourg

 

MISSED THE PREVIOUS 2026 EDITIONS? CHECK THEM HERE:

Read the January Newsletter

READ IT HERE

Read the February Newsletter

READ IT HERE

Read the March Newsletter

READ IT HERE

Read the April Newsletter

READ IT HERE

Read the May Newsletter

READ IT HERE

Read the June Newsletter

READ IT HERE

Read the July Newsletter

READ IT HERE

Read the August Newsletter

READ IT HERE